Testicular cancer differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 60: | Line 60: | ||
* Inhomogenous feature in larger mass | * Inhomogenous feature in larger mass | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | Embryonal carcinoma | | style="background: #DCDCDC; padding: 5px; text-align: center;" | Embryonal carcinoma<ref name="pmid19066212">{{cite journal| author=Ishida M, Hasegawa M, Kanao K, Oyama M, Nakajima Y| title=Non-palpable testicular embryonal carcinoma diagnosed by ultrasound: a case report. | journal=Jpn J Clin Oncol | year= 2009 | volume= 39 | issue= 2 | pages= 124-6 | pmid=19066212 | doi=10.1093/jjco/hyn141 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19066212 }}</ref> | ||
| style="background: #F5F5F5; padding: 5px;" |Malignant | | style="background: #F5F5F5; padding: 5px;" |Malignant | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 84: | Line 84: | ||
* Primitive epithelial cells with marked pleomorphism | * Primitive epithelial cells with marked pleomorphism | ||
* Often mixed histopathological features (solid, papillary, tubular, pseudoglandular) | * Often mixed histopathological features (solid, papillary, tubular, pseudoglandular) | ||
| style="background: #F5F5F5; padding: 5px;" |+ | | style="background: #F5F5F5; padding: 5px;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |± | | style="background: #F5F5F5; padding: 5px;" |± | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | |
Revision as of 17:44, 23 January 2019
Testicular cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Testicular cancer differential diagnosis On the Web |
American Roentgen Ray Society Images of Testicular cancer differential diagnosis |
Risk calculators and risk factors for Testicular cancer differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]
Overview
Testicular cancer must be differentiated from epididymitis, hematocele, hydrocele, spermatocele, granulomatous orchitis, and varicocele.
Differentiating Testicular cancer from other Diseases
Testicular cancer must be differentiated from:
Diseases | Benign/ Malignant | Unilateral/Bilateral | History | Demography | Metastasis | Genetics | Histopathology | Clinical manifestations | Para-clinical findings | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pain | Mass | Physical examination | |||||||||||
Lab Findings | Imaging | ||||||||||||
Germ Cell | Seminoma[1][2] | Malignant | Unilateral |
|
|
|
Stains positively for:
|
|
- | + |
|
|
Ultrasound:
|
Embryonal carcinoma[3] | Malignant |
|
|
|
Early metastasis to:
|
Stains positively for:
May stain positively for :
|
|
+ | ± |
|
|
Ultrasound:
| |
Yolk sac tumor | |||||||||||||
Teratoma | |||||||||||||
Choriocarcinoma | |||||||||||||
Diseases | Benign/ Malignant | Unilateral/Bilateral | History | Demography | Metastasis | Genetics | Histopathology | Pain | Mass | Physical exam | Lab Findings | Imaging | |
Non germ cell | Leydig cell tumor | ||||||||||||
Sertoli cell tumor | |||||||||||||
Testicular lymphoma | |||||||||||||
Carcinoma in situ of the testicle |
References
- ↑ Siegel RL, Miller KD, Jemal A (2016). "Cancer statistics, 2016". CA Cancer J Clin. 66 (1): 7–30. doi:10.3322/caac.21332. PMID 26742998.
- ↑ Miller FH, Whitney WS, Fitzgerald SW, Miller EI (1999). "Seminomas complicating undescended intraabdominal testes in patients with prior negative findings from surgical exploration". AJR Am J Roentgenol. 172 (2): 425–8. doi:10.2214/ajr.172.2.9930796. PMID 9930796.
- ↑ Ishida M, Hasegawa M, Kanao K, Oyama M, Nakajima Y (2009). "Non-palpable testicular embryonal carcinoma diagnosed by ultrasound: a case report". Jpn J Clin Oncol. 39 (2): 124–6. doi:10.1093/jjco/hyn141. PMID 19066212.